Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Interim Management Statement

9 Jan 2015 11:47

RNS Number : 7841B
Unicorn AIM VCT PLC
09 January 2015
 



Unicorn AIM VCT plc

Interim Management Statement

For the period from 1 October 2014 to 31 December 2014.

 

 

Introduction

 

The Company has prepared this Interim Management Statement for the three month period ended 31 December 2014, together with relevant information up to the date of publication.

 

Investment Objective

 

The Company's objective is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maintaining a steady flow of dividend distributions to Shareholders from the income as well as capital gains generated by the portfolio.

 

It is also the objective that the Company should continue to qualify as a Venture Capital Trust, so that Shareholders benefit from the taxation advantages that this brings. To achieve this at least 70% of the Company's total assets are to be invested in qualifying investments of which 30% by VCT value (70% for funds raised after 6 April 2011) must be in ordinary shares which carry no preferential rights (save as permitted under VCT rules) to dividends or return of capital and no rights to redemption.

 

Performance

 

As at 31 December 2014, the unaudited Net Asset Value (NAV) was 144.6 pence per share, compared to an audited NAV of 143.7 pence per share as at 30 September 2014. In the three months ended 31 December 2014, NAV therefore increased by 0.6%. By comparison, the FTSE All-Share Index (excluding investment trusts) rose by 0.5%, while the FTSE AIM All-Share Index declined by 6.0%. NAV and Index performance is calculated on a total return basis, after adding back dividends paid. No dividends were paid by the Company during the period.

 

UK equity markets ended the period almost unchanged, but this performance, masks a relatively volatile three months during which the FTSE All-Share Index rose or fell in value by at least 6% on four different occasions. Notwithstanding the increased volatility of the wider market and poor share price performance from a small number of stocks, the total return from the portfolio was positive in the period.

 

The share prices of Eclectic Bars, Photonstar, Pressure Technologies and Tangent all fell by more than 20% as the market reacted to cautious outlook statements from the management teams of these businesses.

 

In contrast, twelve of the holdings in the portfolio increased in value by more than 10%. In percentage terms, the standout performance came from Castleton Technology, a provider of software and managed services, the shares of which rose by 64% in the period following an issue of new equity to help fund a potentially transformational acquisition. In absolute terms, the positive contributions from Abcam (+15.8%), Anpario (+14.9%) and Tracsis (+13.5%) made the greatest impact, being the three largest holdings in the portfolio by value.

 

 

 

Material Transactions

 

Five follow-on investments were made during the period. The total cost of these purchases was just over £2 million.

 

In order to manage stock specific risk effectively and to maintain appropriate cash balances, a partial disposal in Mears Group was also made. This partial realisation generated cash proceeds of £1.6 million.

 

 

 

Top 10 Equity Holdings as at 31 December 2014

 

Stock % of net assets

 

Abcam 8.4%

 

Tracsis 7.4%

Anpario 6.1%

 

Mattioli Woods 4.6%

 

Crawshaw 3.9%

 

Cohort 3.1%

 

Animalcare Group 2.1%

 

WYG 2.1%

 

Unicorn Mastertrust Fund 2.1%

 

Idox 2.0%

 

Total 41.8%

 

 

Share Buy-Backs/Issue of Equity

 

During the period from 1 October 2014 to 31 December 2014, the Company bought back 495,000 of its own ordinary shares at an average price of 128.4 pence per share. The average discount to the net asset value per share at which the shares were bought back during the period was 9.8%.

 

Three allotments were made in the period under review, in connection with the £15 million Offer for Subscription, launched on 17 September 2014. A total of 4,312,888 new Ordinary Shares were issued at prices ranging between 141.9 and 149.9 pence per share.

 

As a result of these transactions, the total number of shares in issue at the period end was 67,986,000.

 

 

Material Events

 

There were no other material events during the period from 1 October 2014 to 31 December 2014.

 

 

 

Contact details for further enquiries:

 

Chris Hutchinson of Unicorn Asset Management Limited (the Investment Manager),

on 020 7253 0889.

 

Jon Carslake at ISCA Administration Services Limited (the Company Secretary)

on 01392 487056 or by e-mail on unicornaimvct@iscaadmin.co.uk

 

 

9 January 2015

 

DISCLAIMER

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website:- www.unicornaimvct.co.uk (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDMGGMMLKGKZM
Date   Source Headline
14th Dec 20227:00 amRNSFinal Results
8th Dec 202210:12 amRNSIntention to Launch an Offer
5th Dec 20222:43 pmRNSNet Asset Value(s)
4th Nov 20225:47 pmRNSNet Asset Value(s)
21st Oct 20221:38 pmRNSNet Asset Value(s)
3rd Oct 202212:45 pmRNSTotal Voting Rights
20th Sep 20226:19 pmRNSTransaction in Own Shares
5th Sep 202212:32 pmRNSNet Asset Value(s)
11th Aug 202211:27 amRNSIssue of Equity
4th Aug 20222:47 pmRNSNet Asset Value(s)
26th Jul 202211:30 amRNSInterim Management Statement
7th Jul 20229:50 amRNSNet Asset Value(s)
1st Jul 202210:00 amRNSTotal Voting Rights
22nd Jun 20225:44 pmRNSTransaction in Own Shares
14th Jun 20223:27 pmRNSNet Asset Value(s)
10th Jun 20227:00 amRNSHalf-year Report
24th May 20222:26 pmRNSDirectorate Change
6th May 202212:33 pmRNSNet Asset Value(s)
11th Apr 20229:02 amRNSNet Asset Value(s) Replacement
7th Apr 20223:14 pmRNSNet Asset Value(s)
1st Apr 202210:43 amRNSTotal Voting Rights
10th Mar 20227:00 amRNSTransaction in Own Shares
4th Mar 20221:40 pmRNSDirector/PDMR Shareholding
4th Mar 202212:44 pmRNSTotal Voting Rights
4th Mar 202212:39 pmRNSIssue of Equity
2nd Mar 20222:26 pmRNSNet Asset Value(s)
1st Mar 20229:58 amRNSTotal Voting Rights
18th Feb 20221:27 pmRNSInterim Management Statement
15th Feb 20224:51 pmRNSTransaction in Own Shares
10th Feb 20227:00 amRNSIssue of Equity
9th Feb 202212:11 pmRNSOffer for Subscription - Update
7th Feb 202210:12 amRNSNet Asset Value(s)
3rd Feb 20221:34 pmRNSResult of AGM
1st Feb 202211:52 amRNSTotal Voting Rights
24th Jan 202210:17 amRNSOffer for Subscription and Issue of Prospectus
17th Jan 202212:44 pmRNSTransaction in Own Shares
6th Jan 20222:49 pmRNSNet Asset Value(s)
4th Jan 20229:41 amRNSTotal Voting Rights
20th Dec 20215:30 pmRNSTransaction in Own Shares
16th Dec 202112:33 pmRNSConfirmation of Dividends
14th Dec 20211:48 pmRNSNet Asset Value(s)
8th Dec 20217:00 amRNSFinal Results
22nd Nov 20215:07 pmRNSDeclaration of Special Dividend
4th Nov 20215:47 pmRNSNet Asset Value(s)
26th Oct 20213:07 pmRNSIntention to launch an Offer
18th Oct 20214:34 pmRNSNet Asset Value(s)
1st Oct 202111:46 amRNSTotal Voting Rights
10th Sep 20213:52 pmRNSTransaction in Own Shares
1st Sep 20212:46 pmRNSTotal Voting Rights
16th Aug 202110:57 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.